Zhang Q, McDermott G, Juge P, Chang S, Vanni K, Qian G
Semin Arthritis Rheum. 2024; 69:152561.
PMID: 39413452
PMC: 11606763.
DOI: 10.1016/j.semarthrit.2024.152561.
Mena-Vazquez N, Rojas-Gimenez M, Fuego-Varela C, Garcia-Studer A, Perez-Gomez N, Romero-Barco C
Biomedicines. 2022; 10(7).
PMID: 35884786
PMC: 9313094.
DOI: 10.3390/biomedicines10071480.
Tardella M, Di Carlo M, Carotti M, Giovagnoni A, Salaffi F
Clin Rheumatol. 2021; 40(12):4861-4867.
PMID: 34313866
PMC: 8599404.
DOI: 10.1007/s10067-021-05854-w.
Picchianti Diamanti A, Rosado M, Pioli C, Sesti G, Lagana B
Int J Mol Sci. 2020; 21(9).
PMID: 32397174
PMC: 7247555.
DOI: 10.3390/ijms21093330.
Cassone G, Manfredi A, Vacchi C, Luppi F, Coppi F, Salvarani C
J Clin Med. 2020; 9(4).
PMID: 32290218
PMC: 7230307.
DOI: 10.3390/jcm9041082.
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study.
Cassone G, Manfredi A, Atzeni F, Venerito V, Vacchi C, Picerno V
J Clin Med. 2020; 9(1).
PMID: 31963908
PMC: 7019755.
DOI: 10.3390/jcm9010277.
Current and Emerging Drug Therapies for Connective Tissue Disease-Interstitial Lung Disease (CTD-ILD).
Jee A, Corte T
Drugs. 2019; 79(14):1511-1528.
PMID: 31399860
DOI: 10.1007/s40265-019-01178-x.
Thoracic Manifestations of Rheumatoid Arthritis.
Esposito A, Chu S, Madan R, Doyle T, Dellaripa P
Clin Chest Med. 2019; 40(3):545-560.
PMID: 31376890
PMC: 6994971.
DOI: 10.1016/j.ccm.2019.05.003.
Comprehensive review of current diagnostic and treatment approaches to interstitial lung disease associated with rheumatoid arthritis.
Bes C
Eur J Rheumatol. 2019; 6(3):146-149.
PMID: 31364981
PMC: 6668644.
DOI: 10.5152/eurjrheum.2019.19036.
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 5. Connective Tissue Disease Associated Interstitial Lung Disease.
Koo S, Kim S, Choi S, Lee H
Tuberc Respir Dis (Seoul). 2019; 82(4):285-297.
PMID: 31172701
PMC: 6778739.
DOI: 10.4046/trd.2019.0009.
Biologic Treatments in Interstitial Lung Diseases.
Karampitsakos T, Vraka A, Bouros D, Liossis S, Tzouvelekis A
Front Med (Lausanne). 2019; 6:41.
PMID: 30931306
PMC: 6425869.
DOI: 10.3389/fmed.2019.00041.
Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
Kurata I, Tsuboi H, Terasaki M, Shimizu M, Toko H, Honda F
Intern Med. 2019; 58(12):1703-1712.
PMID: 30799358
PMC: 6630137.
DOI: 10.2169/internalmedicine.2226-18.
Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
Wu E, Ambrosini R, Kottmann R, Ritchlin C, Schwarz E, Rahimi H
Curr Rheumatol Rev. 2019; 15(4):277-289.
PMID: 30652645
PMC: 6629516.
DOI: 10.2174/1573397115666190116102451.
Immunologist's Perspectives on Assessment and Management of Lung Disease in CVID: a Survey of the Membership of the Clinical Immunology Society and the European Society for Immunodeficiencies.
Akhter J, Lefaiver C, Scalchunes C, DiGirolamo M, Warnatz K
J Clin Immunol. 2018; 38(3):237-246.
PMID: 29629482
DOI: 10.1007/s10875-018-0488-9.
Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Koo S, Uh S
Korean J Intern Med. 2017; 32(4):600-610.
PMID: 28704913
PMC: 5511941.
DOI: 10.3904/kjim.2016.212.
Treatment of rheumatoid arthritis-associated interstitial lung disease: a perspective review.
Iqbal K, Kelly C
Ther Adv Musculoskelet Dis. 2015; 7(6):247-67.
PMID: 26622326
PMC: 4637848.
DOI: 10.1177/1759720X15612250.
